• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Primary biliary cirrhosis at Hospital Kuala Lumpur: a study of 17 cases seen between 1992 and 1999.

作者信息

Kananathan R, Suresh R L, Merican I

机构信息

Department of Medicine, Hospital Kuala Lumpur, 50586, Jalan Pahang, Kuala Lumpur.

出版信息

Med J Malaysia. 2002 Mar;57(1):56-60.

PMID:14569718
Abstract

A prospective descriptive study of Primary Biliary Cirrhosis at Hospital Kuala Lumpur was undertaken from January 1992 to December 1999. A total of 17 patients were seen with a female to male ratio of 3.25:1. The mean age at presentation was 45.9 years (range: 14 years to 67 years) with a mean follow-up of 33.4 months (range: 3 months to 95 months). Fatigue was the most common clinical symptom at presentation. Alanine transaminase and alkaline phosphatase levels were elevated in 93% of patients at presentation. The antimitochondrial antibody was positive in 87% of patients. Ursodeoxycholic acid therapy resulted in significant symptomatic relief and biochemical improvement in all those who were treated.

摘要

相似文献

1
Primary biliary cirrhosis at Hospital Kuala Lumpur: a study of 17 cases seen between 1992 and 1999.
Med J Malaysia. 2002 Mar;57(1):56-60.
2
[Primary biliary cirrhosis. The experience in 33 consecutive cases].[原发性胆汁性肝硬化。33例连续病例的经验]
Rev Med Chil. 1990 Dec;118(12):1344-9.
3
Primary biliary cirrhosis--experience in University Hospital, Kuala Lumpur.原发性胆汁性肝硬化——吉隆坡大学医院的经验
Med J Malaysia. 1996 Mar;51(1):99-102.
4
Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.甲氨蝶呤用于对熊去氧胆酸治疗生化反应不完全的原发性胆汁性肝硬化患者进行症状性治疗。
Aliment Pharmacol Ther. 2006 Sep 1;24(5):813-20. doi: 10.1111/j.1365-2036.2006.03048.x.
5
[Primary biliary liver cirrhosis in patients treated at Szczecin hospitals in 1978-1988].[1978年至1988年在什切青医院接受治疗的原发性胆汁性肝硬化患者]
Pol Tyg Lek. 1991;46(14-16):254-5.
6
Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis.无症状原发性胆汁性肝硬化:其自然史与预后研究
Am J Gastroenterol. 1999 Jan;94(1):47-53. doi: 10.1111/j.1572-0241.1999.00770.x.
7
Primary biliary cirrhosis in India.印度的原发性胆汁性肝硬化
Hepatobiliary Pancreat Dis Int. 2006 Feb;5(1):105-9.
8
Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.熊去氧胆酸长期治疗原发性胆汁性肝硬化:长达12年的随访
Aliment Pharmacol Ther. 2005 Feb 1;21(3):217-26. doi: 10.1111/j.1365-2036.2005.02318.x.
9
Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.原发性胆汁性肝硬化(I期)对熊去氧胆酸治疗的长期反应。
Hepatogastroenterology. 2005 May-Jun;52(63):753-6.
10
Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic population.
J Gastroenterol Hepatol. 2008 Apr;23(4):599-605. doi: 10.1111/j.1440-1746.2007.05058.x. Epub 2007 Jul 20.